{
    "2018-11-29": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Cramer's lightning round: Buy DowDuPont—the breakup-related pain is over",
                "features": {
                    "keywords": [
                        "Cramer",
                        "lightning round",
                        "Buy",
                        "DowDuPont",
                        "breakup-related",
                        "pain",
                        "over"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "industrials"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Analysts Remain Bullish on Align Stock",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Bullish",
                        "Align",
                        "Stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "What Investors Should Know about Align’s Operational Performance",
                "features": {
                    "keywords": [
                        "Investors",
                        "Operational",
                        "Performance",
                        "Align"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "How Is Align Technology Positioned in November?",
                "features": {
                    "keywords": [
                        "Align",
                        "Technology",
                        "Positioned",
                        "November"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}